Evidence map›Paper›PMID 42572742›Full record

ArticleDrug design, development and therapy2026

Solvent-Free One-Pot Preparation of Lignin-Ferric Nanoparticles for Enhanced Antibacterial Therapy.

Xiuliang Dai, Ruitong Liu, Yujie Zhou, Tingting Fan, Cheng Wang, Hongbin Xu

Abstract read
In one paragraph

Article in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiuliang DaiThe Center for Reproductive Medicine, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu, People's Republic of China.
Ruitong LiuObstetrics and Gynecology Department, The Second People's Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, People's Republic of China.
Yujie ZhouSchool of Pharmacy, Changzhou University, Changzhou, Jiangsu, People's Republic of China.
Tingting FanObstetrics and Gynecology Department, The Second People's Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, People's Republic of China.
Cheng WangSchool of Pharmacy, Changzhou University, Changzhou, Jiangsu, People's Republic of China.ORCID 0000-0003-3873-7350
Hongbin XuObstetrics and Gynecology Department, The Second People's Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The global rise of antibiotic-resistant bacterial infections has intensified the need for scalable and biocompatible antimicrobial nanomaterials. Lignin is an abundant renewable biopolymer with intrinsic antimicrobial activity, but its limited aqueous processability and modest antibacterial efficacy restrict its direct application. Methods: Lignin-ferric nanoparticles (LS-Fe) were prepared through an aqueous one-pot process using sodium lignosulfonate (SLS) as the lignin precursor and Fe Results: LS-Fe formed stable colloidal nanoparticles with a hydrodynamic diameter of 126.63 nm, a polydispersity index of 0.19, and a zeta potential of -44.7 mV. In preliminary in vitro assays, LS-Fe showed a descriptive trend toward greater antibacterial activity than pristine SLS against both bacterial strains. LS-Fe treatment was associated with increased intracellular ROS and lipid peroxidation, bacterial membrane damage, inhibition of biofilm formation, and reduced residual biomass of preformed biofilms. The attenuation of LS-Fe-mediated antibacterial activity by deferoxamine, thiourea, and catalase, together with its enhancement by exogenous H Conclusion: Aqueous one-pot preparation of LS-Fe provides a simple organic-solvent-free strategy for integrating lignin nanoparticle formation with ferric functionalization. The preliminary findings support further investigation of LS-Fe as a sustainable antibacterial nanomaterial for infected-wound management, while larger confirmatory studies and more comprehensive mechanistic and safety evaluations remain necessary.

Indexed as

Anti-Bacterial AgentsFerric CompoundsLigninNanoparticlesStaphylococcus aureusAnimalsBiofilmsDose-Response Relationship, DrugEscherichia coliMiceMicrobial Sensitivity TestsParticle SizeReactive Oxygen SpeciesStaphylococcal InfectionsAnti-Bacterial AgentsFerric CompoundsLigninReactive Oxygen Speciesantibacterial therapyferric coordinationlignin nanoparticlesone-pot synthesiswound healing

Identifiers

PMID42572742
PMCPMC13453422

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.